In addition, a study comparing pre-treatment AMH levels in young cancer patients (<18 years) with age-matched non-cancer patients was conducted by Van et al. in 2014 [19], where AMH levels were found to be significantly lower in cancer patients [19]. This evidence concerns the gene AMH and cancer.